CTVA Price Prediction Next Week
CTVA Stock Price Prediction and Recommendation
Based on the analysis of news sentiment, technical indicators, and recent developments, here is the prediction for Corteva (CTVA) stock for the next trading week:
Predicted Price: $59.93
Recommendation: Sell
This prediction is based on the following factors:
- Technical Indicators: CTVA is currently oversold, with an RSI of 34.69, indicating a potential short-term bounce. However, the MACD remains bearish, suggesting limited upside.
- News Sentiment: Negative insider sentiment and potential tariff impacts on agricultural costs could weigh on the stock.
- Support Levels: The stock is approaching a critical support level at $59.93, which may trigger a sell signal if broken.
The stock is expected to test the lower end of its Fibonacci support range, making it a risky bet for buyers in the short term.
CTVA Similar Chart Price Prediction
The price of CTVA is predicted to go up 3.58%, based on the high correlation periods with ENB. The similarity of these two price pattern on the periods is 94.78%.
CTVA
ENB
Up: 3.58%Similarity: 94.78%
CTVA Revenue Forecast
CTVA EPS Forecast
CTVA FAQs
What is CTVA revenue forecast for next quarter？
What is CTVA eps forecast for next quarter？
CTVA VS S&P500
Corteva's profits will see a boost from the expiration of a $1 billion annual royalty payment to Bayer in 2023.
Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.
Corteva's strong pipeline of patented crop protection chemicals will drive profits and margins higher as the company expands its proportion of sales from patented and differentiated crop protection products.
CTVA Analyst's Forecast
Benjamin Theurer
Barclays
Hold
2025-01-21
Price Target
$62 → $64
Upside
+1.39%
Barclays analyst Benjamin Theurer raised the firm's price target on Corteva to $64 from $62 and keeps an Equal Weight rating on the shares. Entering 2025, the firm is more optimistic about crop protection and maintains a positive outlook on diversified international protein names and ingredients. In contrast, Barclays adds caution to its grain processor coverage and adjusted ratings in fertilizer given the recent run-up in share prices. It recognizes the strength in potash volumes in 2024 did not bring stock appreciation for the major potash players.
Joshua Spector
UBS
Strong Buy
2025-01-10
Price Target
$74 → $73
Upside
+27.87%
Aleksey Yefremov
Keybanc
Buy
2025-01-10
Price Target
$69 → $68
Upside
+19.11%
